Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Talengen Institute Of Life Sciences, Shenzhen, P.r. China.

Clinical trials sponsored by Talengen Institute Of Life Sciences, Shenzhen, P.r. China., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New ALS drug TP04HN106 enters human trials Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New ALS drug TP04HN106 enters human trials

Disease control Recruiting now

This study tests an experimental drug called TP04HN106 in 60 people with ALS. Half receive the drug, half receive a placebo (saline), and all take riluzole tablets as standard care. The goal is to see if the drug is safe and can slow the decline in physical function measured by t…

Phase 1/2 • Sponsor: Talengen Institute of Life Sciences, Shenzhen, P.R. China. • Aim: Disease control

Last updated Jun 27, 2026 12:29 UTC